Trinity Biotech (TRIB) Net Income Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Net Income Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | 125.69% |
| 10 | Trinity Biotech | 111.52 Mn | 106.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -208.16% |
| Sep 30, 2024 | 28.15% |
| Jun 30, 2024 | -156.80% |
| Mar 31, 2024 | -741.73% |
| Dec 31, 2023 | 45.42% |
| Sep 30, 2023 | 24.86% |
| Jun 30, 2023 | 2,899.51% |
| Mar 31, 2023 | -37.29% |
| Dec 31, 2022 | -40,220.00% |
| Sep 30, 2022 | -30,744.83% |
| Jun 30, 2022 | -21.82% |
| Mar 31, 2022 | -82.00% |
| Dec 31, 2021 | 99.83% |
| Sep 30, 2021 | -100.35% |
| Jun 30, 2021 | -69.99% |
| Mar 31, 2021 | 42.43% |
| Dec 31, 2020 | 59.87% |
| Sep 30, 2020 | 2,441.54% |
| Jun 30, 2020 | -69.50% |
| Mar 31, 2020 | 858.07% |